Acne fulminans (AF) is a rare, acute, and severe form of acne vulgaris often associated with systemic symptoms. Its treatment is challenging and controversial. We report a case of isotretinoin-induced AF (IIAF) in a 12-year-old boy resistant to traditional therapies (oral steroids and isotretinoin). The patient was successfully treated with adalimumab that can be considered an effective off-label option in the treatment of resistant IIAF in children.
Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case / Marasca, C.; Fabbrocini, G.; Abategiovanni, L.; Camela, E.; Nocerino, M.; Di Guida, A.; De Fata Salvatores, G.. - In: SKIN APPENDAGE DISORDERS. - ISSN 2296-9195. - 7:2(2021), pp. 115-119. [10.1159/000512032]
Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case
Marasca C.;Fabbrocini G.;Abategiovanni L.;Camela E.;Nocerino M.;Di Guida A.;De Fata Salvatores G.
2021
Abstract
Acne fulminans (AF) is a rare, acute, and severe form of acne vulgaris often associated with systemic symptoms. Its treatment is challenging and controversial. We report a case of isotretinoin-induced AF (IIAF) in a 12-year-old boy resistant to traditional therapies (oral steroids and isotretinoin). The patient was successfully treated with adalimumab that can be considered an effective off-label option in the treatment of resistant IIAF in children.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
